Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.

Faut M, Wevers KP, van Ginkel RJ, Diercks GF, Hoekstra HJ, Kruijff S, Been LB, van Leeuwen BL.

Ann Surg Oncol. 2017 Jan;24(1):142-149. doi: 10.1245/s10434-016-5566-8. Epub 2016 Sep 19.

2.

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Han D, Thomas DC, Zager JS, Pockaj B, White RL, Leong SP.

World J Clin Oncol. 2016 Apr 10;7(2):174-88. doi: 10.5306/wjco.v7.i2.174. Review.

3.

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.

Lee DY, Huynh KT, Teng A, Lau BJ, Vitug S, Lee JH, Stern SL, Foshag LJ, Faries MB.

Ann Surg Oncol. 2016 Mar;23(3):1012-8. doi: 10.1245/s10434-015-4912-6. Epub 2015 Nov 19.

4.

Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy.

Salama AK, de Rosa N, Scheri RP, Pruitt SK, Herndon JE 2nd, Marcello J, Tyler DS, Abernethy AP.

PLoS One. 2013;8(3):e57665. doi: 10.1371/journal.pone.0057665. Epub 2013 Mar 13.

5.

Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.

Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, Kounalakis N, Gonzalez R, Lewis KD, Robinson WA, McCarter MD.

JAMA Surg. 2013 May;148(5):456-61. doi: 10.1001/jamasurg.2013.1335.

6.

Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009).

Biver-Dalle C, Puzenat E, Puyraveau M, Delroeux D, Boulahdour H, Sheppard F, Pelletier F, Humbert P, Aubin F.

BMC Dermatol. 2012 Dec 10;12:21. doi: 10.1186/1471-5945-12-21.

7.

Optical clearing of archive-compatible paraffin embedded tissue for multiphoton microscopy.

Wilson JW, Degan S, Warren WS, Fischer MC.

Biomed Opt Express. 2012 Nov 1;3(11):2752-60. doi: 10.1364/BOE.3.002752. Epub 2012 Oct 3. Erratum in: Biomed Opt Express. 2013 Feb;4(2):219.

8.

Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma.

Page AJ, Li A, Hestley A, Murray D, Carlson GW, Delman KA.

Int J Surg Oncol. 2012;2012:456987. doi: 10.1155/2012/456987. Epub 2012 Mar 18.

9.

Prognosis of sentinel node staged patients with primary cutaneous melanoma.

Elsaesser O, Leiter U, Buettner PG, Eigentler TK, Meier F, Weide B, Metzler G, Breuninger H, Garbe C.

PLoS One. 2012;7(1):e29791. doi: 10.1371/journal.pone.0029791. Epub 2012 Jan 19.

10.

Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model.

Khullar OV, Griset AP, Gibbs-Strauss SL, Chirieac LR, Zubris KA, Frangioni JV, Grinstaff MW, Colson YL.

J Am Coll Surg. 2012 Mar;214(3):328-37. doi: 10.1016/j.jamcollsurg.2011.11.006. Epub 2012 Jan 5.

11.
12.

Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management.

Hasney C, Butcher RB 2nd, Amedee RG.

Ochsner J. 2008 Winter;8(4):181-5. No abstract available.

13.

Staging and prognosis of cutaneous melanoma.

Dickson PV, Gershenwald JE.

Surg Oncol Clin N Am. 2011 Jan;20(1):1-17. doi: 10.1016/j.soc.2010.09.007. Review.

14.

Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).

Warycha MA, Zakrzewski J, Ni Q, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Osman I.

Cancer. 2009 Feb 15;115(4):869-79. doi: 10.1002/cncr.24044.

15.

Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making.

Alkhatib W, Hertzenberg C, Jewell W, Al-Kasspooles MF, Damjanov I, Cohen MS.

Am J Surg. 2008 Dec;196(6):827-32; discussion 832-3. doi: 10.1016/j.amjsurg.2008.07.034.

16.

Surgery and sentinel lymph node biopsy.

Faries MB, Morton DL.

Semin Oncol. 2007 Dec;34(6):498-508. Review.

17.

The role of sentinel lymph node biopsy in the management of melanoma.

Amersi F, Morton DL.

Adv Surg. 2007;41:241-56. Review.

18.

Sentinel lymph node biopsies in cancers of the skin, colon, head and neck, and breast.

Nelson BM.

Proc (Bayl Univ Med Cent). 2004 Apr;17(2):99-103. No abstract available.

19.

The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.

Sahni D, Robson A, Orchard G, Szydlo R, Evans AV, Russell-Jones R.

J Clin Pathol. 2005 Jul;58(7):715-21.

20.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

Supplemental Content

Support Center